These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5712728)

  • 1. Altitude-induced alterations in drug action and metabolism.
    Merritt JH; Medina MA
    Life Sci; 1968 Nov; 7(21):1163-9. PubMed ID: 5712728
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance experiments with barbitone-dependent rats.
    Turnbull MJ; Stevenson IH
    J Pharm Pharmacol; 1968 Nov; 20(11):884-5. PubMed ID: 4387501
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of water deprivation on the metabolism of hexobarbital in the Mongolian gerbil (Meriones unguiculatus).
    Maines MD; Westfall BA
    Comp Gen Pharmacol; 1971 Sep; 2(7):311-6. PubMed ID: 5162667
    [No Abstract]   [Full Text] [Related]  

  • 4. Hexobarbitone response in barbitone-dependent and withdrawn rats.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1968 Sep; 34(1):210P-211P. PubMed ID: 5692083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium--drug metabolism and drug action. 6. Duration of sleep induced by hexobarbital following thyroidectomy hexobarbital metabolism].
    Tochino Y; Matsubarat ; Takase H
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):85-6. PubMed ID: 5531425
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and environmental factors affecting hexobarbital metabolism in mice.
    Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):900-12. PubMed ID: 5263697
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B; Alexanderson B; Sjöqvist F
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyaluronidase and sleep].
    Safta L; Cuparencu B; Mierut G; Zillmann J
    Anesth Analg (Paris); 1972; 29(1):52-7. PubMed ID: 5069152
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of brain sensitivity and hepatic metabolism of hexobarbitone to dose-response relations in infant and young rats.
    Kalser SC; Forbes E; Kunig R
    J Pharm Pharmacol; 1969 Feb; 21(2):109-13. PubMed ID: 4388087
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of microsomal drug metabolism by methylenedioxybenzenes.
    Anders MW
    Biochem Pharmacol; 1968 Nov; 17(11):2367-70. PubMed ID: 5718145
    [No Abstract]   [Full Text] [Related]  

  • 13. Sexual dimorphism and the effects of the X-linked Tfm locus on hexobarbitone metabolism and action in mice.
    King DK; Shapiro BH
    Br J Pharmacol; 1981 Sep; 74(1):97-104. PubMed ID: 7196788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dose-sleeping time lines of hexobarbital in mice.
    Noordhoek J
    Eur J Pharmacol; 1968 Jun; 3(3):242-50. PubMed ID: 5673637
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment of hepatic drug metabolism in calcium deficiency.
    Dingell JV; Joiner PD; Hurwitz L
    Biochem Pharmacol; 1966 Jul; 15(7):971-6. PubMed ID: 5967908
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance development to cadmium-induced alteration of drug action.
    Roberts SA; Miya TS; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):197-200. PubMed ID: 935651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
    Tsujimoto A; Doi T; Ikeda M; Nishikawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):264-73. PubMed ID: 4447408
    [No Abstract]   [Full Text] [Related]  

  • 18. An investigation of the decrease in the metabolism of hexobarbital, aminopyrine and p-nitrobenzoic acid by liver from rats bearing a pituitary mammotropic tumor.
    Wilson JT
    J Pharmacol Exp Ther; 1968 Mar; 160(1):179-88. PubMed ID: 5639103
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain disposition, liver metabolism and behavioural responses to barbiturates in inbred "sensitive" and "resistant" mice.
    Halevy S; Frumin MJ; Rosenthal S; Levine WG
    Br J Anaesth; 1974 Jan; 46(1):43-9. PubMed ID: 4820933
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.